Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023

SELL
$161.33 - $204.36 $5.63 Million - $7.13 Million
-34,900 Reduced 94.58%
2,000 $363,000
Q4 2022

Feb 10, 2023

BUY
$191.53 - $236.82 $383,060 - $473,640
2,000 Added 5.73%
36,900 $7.25 Million
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $4.32 Million - $9.68 Million
34,900 New
34,900 $7.85 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.